- Financial Times•1 hour ago
Pfizer, the world's top drugmaker by revenues, has warned that a strengthening dollar would be "a very big challenge" for the company in 2017, raising concerns for US corporations that generate ...
- Reuters•7 hours ago
Two decades after they were spurred into action to tackle AIDS in Africa, global drugmakers said on Wednesday they would invest $50 million over three years to fight cancer and other non-communicable diseases in poor countries. Twenty-two companies, including Pfizer, Merck , Novartis, Roche, Sanofi and GlaxoSmithKline, will contribute funds and expertise to the project, which is backed by the World Bank. The so-called Access Accelerated initiative was announced at the World Economic Forum in Davos and aims to improve both treatment and prevention.
- CNBC•13 hours ago
Pfizer thinks the solution to high drug prices is to raise prices.
PFE : Summary for Pfizer, Inc. Common Stock - Yahoo Finance
Pfizer Inc. (PFE)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||31.78 - 32.38|
|52 Week Range||28.25 - 37.39|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||32.19|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|